Publication | Open Access
Tumor Stromal Disrupting Agent Enhances the Anticancer Efficacy of Docetaxel Loaded PEGylated Liposomes in Lung Cancer
50
Citations
33
References
2016
Year
Combination of DTXPL with telmisartan could significantly enhance clinical outcome in lung cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1